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Bloodstream infections rank among the most serious causes of morbidity and mortality in hospitalized
patients, partly due to the long period (up to one week) required for clinical diagnosis. In this work, we
have developed a sensitive method to quickly and accurately identify bacteria in human blood samples
by combining optimized matrix-assisted laser desorption/ionization time-of-ﬂight mass spectrometry
(MS) and eﬃcient immunoaﬃnity enrichment/separation. A library of bacteria reference mass spectra at
diﬀerent cell numbers was ﬁrstly built. Due to a reduced sample spot size, the reference spectra could
be obtained from as few as 10 to 102 intact bacterial cells. Bacteria in human blood samples were then
extracted using antibodies-modiﬁed magnetic beads for MS ﬁngerprinting. By comparing the sample
spectra with the reference spectra based on a cosine correlation, bacteria with concentrations as low as
500 cells per mL in blood serum and 8000 cells per mL in whole blood were identiﬁed. The proposed
method was further applied to positive clinical blood cultures (BCs) provided by a local hospital, where
Escherichia coli and Staphylococcus aureus were identiﬁed. Because of the method’s high sensitivity, the
BC time required for diagnosis can be greatly reduced. As a proof of concept, whole blood spiked with
a low initial concentration (102 or 103 cells per mL) of bacteria was cultured in commercial BC bottles
and analysed by the developed method after diﬀerent BC times. Bacteria were successfully identiﬁed
after 4 hours of BC. Therefore, an entire diagnostic process could be accurately accomplished within
half a day using the newly developed method, which could facilitate the timely determination of
appropriate anti-bacterial therapy and decrease the risk of mortality from bloodstream infections.Introduction
Bloodstream infections (BSI), which are caused by the presence
of bacteria or fungi in the bloodstream, rank among the most
serious causes of morbidity and mortality in hospitalized
patients.1 A systematic review estimated that about 600 000 BSI
episodes occur in North America every year, and aboutalytique, E´cole Polytechnique Fede´rale de
ion, Switzerland. E-mail: hubert.girault@
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tion (ESI) available. See DOI:
hemistry 20161 200 000 BSI episodes aﬀect Europe, resulting in roughly
86 000 and 157 000 deaths, respectively.2 Therefore, the diag-
nosis and treatment of BSIs are of great importance.
Currently, blood culture (BC) methods are regarded as the
“Gold Standard” for BSI diagnosis and have been widely used in
clinical microbiology laboratories. In traditional BCs, large
volume blood samples collected from patients (i.e. 20–30 mL for
an adult, and 1–20mL for a child) are injected into dedicated BC
bottles and are cultured for up to 5 days or even longer
(depending on the bacterial species), followed by hours to days
of subculture and microorganism phenotypic identication.3
The whole identication process takes a relatively long time and
is highly dependent on the personal experience of doctors,
which forfeits BSI diagnosis at early stages of infection and
increases the risk of mortality.
Rapid and accurate identication of bacteria from blood
samples is crucial for eﬀective therapy and the reduction of cost
and stay-time in hospital. At present, genotypic methods, such
as real-time polymerase chain reaction (PCR), uorescence in
situ hybridization (FISH), and 16S ribosomal RNA gene
sequencing, have been developed as alternative approaches forChem. Sci., 2016, 7, 2987–2995 | 2987
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View Article OnlineBSI diagnosis.4,5 However, the stability and reproducibility of
these methods can barely reach the requirements of clinical
diagnosis. Recently, an integrated comprehensive droplet
digital detection method integrating droplet microuidics,
DNAzyme-based sensors, and a high-throughput particle
counter system was developed and could detect a low abun-
dance of bacteria from Escherichia coli-spiked blood samples.6
Compared to other methods for bacteria identication, mass
spectrometry provides sensitive and accurate label-free detec-
tion with high throughput. Since pioneering works in the
1990s,7–9 matrix-assisted laser desorption/ionization time-of-
ight mass spectrometry (MALDI-TOFMS) has been widely used
for bacteria identication at the genus, species and even strain
level.10–12 With this concept, commercial MALDI-TOF MS
systems, including Vitek MS (bioMe´rieux) and Biotyper (Bruker
Daltonics), have been adopted for the identication of a variety
of bacteria from blood samples, and received clearance from the
US Food and Drug Administration (FDA).13–15 However, typical
MALDI-TOF MS identication works only when there is a high
abundance of bacteria and it is unable to identify bacteria
directly from a patient’s blood, where the initial bacteria
concentration is normally low, oen <100 colony forming units
per milliliter (CFU mL1) for adult patients.16,17 Thereby, large
volume blood samples and long term BCs are still needed for
MALDI-TOF MS based BSI diagnosis.
Further improvements in the sensitivity of bacteria identi-
cation from blood samples by MALDI-TOF MS are crucial for
fast BSI diagnosis. This can be realized by two approaches: (i)
more eﬃcient bacteria enrichment/separation, (ii) more sensi-
tive MALDI-TOF MS detection. With respect to the rst
approach, aﬃnity probes have been used for bacteria separa-
tions. For instance, Wu et al. used Fe3O4 NP–graphene nano-
sheets decorated with chitosan to capture pathogenic bacteria
from aqueous suspension, and as low as 500 CFU mL1
Pseudomonas aeruginosa or 450 CFUmL1 Staphylococcus aureus
in water (1 mL) were detected.18 Similarly, commercial anti-
Salmonella Dynabeads® (Lake Success, NY, USA) were used to
selectively isolate Salmonella choleraesuis for MALDI-TOF MS
analysis, where the limit of detection (LOD) was demonstrated
to be 107 cells per mL in water, and 109 cells per mL in human
urine or chicken blood (1 mL).19 With respect to the second
approach, Zenobi et al.20 recently developed functional high-
density micro-arrays for the ultrasensitive analysis of single
cells by MALDI-TOF MS. The micro-arrays were fabricated by
laser ablation on a hydrophobic and organo-phobic layer to
focus sample spots within 100 mm in diameter. In such a way,
cells positions can be easily located, and a higher sample
surface concentration can be achieved, leading to an enhanced
signal-to-noise ratio (S/N) during analysis.
In the present work, a highly eﬃcient immunoaﬃnity
enrichment/separation of bacteria by antibodies-modied
magnetic beads (Abs-MBs) was combined with ultrasensitive
MALDI-TOF MS for bacteria identication from blood samples.
A library of bacteria reference spectra was rst built by collect-
ing the MALDI-TOF MS ngerprints of diﬀerent bacteria at
diﬀerent cell numbers. By reducing the sample spot size to
800 mm, eﬀective reference spectra could be obtained from as2988 | Chem. Sci., 2016, 7, 2987–2995few as 10 to 102 bacterial cells. With this library, bacteria were
identied from blood samples by spectra pattern matching. A
frequently used cosine correlation method was conducted to
calculate a spectral similarity score.21 Identication was reached
based on the highest similarity score and validated with
statistical condence.
The immunoaﬃnity MALDI-TOF MSmethod was tested with
three species of bacteria: Escherichia coli (E. coli), Bacillus subtilis
(B. subtilis) and Staphylococcus aureus (S. aureus). Both E. coli
and S. aureus are among the most common pathogens that
cause BSIs worldwide.22,23 The LODs achieved were 500 cells per
mL in human blood serum and 8000 cells per mL in human
whole blood (1 mL) for all three bacteria. To the best of the
authors' knowledge, these are the lowest reported LODs for
bacteria identication from blood samples by MALDI-TOF MS.
Accuracy of the method was determined with 20 positive and
20 negative control experiments using bacteria-spiked whole
blood samples. Specicity was evaluated with multi-species
spiked whole blood samples.
With high sensitivity, accuracy and specicity, the present
method is promising for BSI diagnosis. To demonstrate this
concept, the method was tested with clinical E. coli or S. aureus
positive BC bottles provided by a local hospital (Hoˆpital du
Valais, Sion, Switzerland), where the bacteria were successfully
identied. Owing to the method’s high sensitivity, the BC time
needed for clinical diagnosis can be reduced. As a proof of
concept, human whole blood spiked with a low initial concen-
tration (102 or 103 cells per mL) of E. coli was cultured in
commercial BacT/Alert® FA Plus BC bottles (bioMe´rieux, Inc.,
Durham, NC) and analysed using the developed method aer
diﬀerent culture times. For both concentrations, E. coli was
successfully identied aer 4 hours of culture.Results and discussion
Direct MALDI-TOF MS ngerprinting of pure bacteria with
high sensitivity to build a library of bacteria reference mass
spectra
The sensitivity of MALDI-TOF MS for direct bacteria nger-
printing was rst investigated using a routine procedure: 1 mL of
a bacterial aqueous solution was directly deposited on a MALDI
target plate and overlaid with a 2,5-dihydroxycinnamic acid
(DHB) matrix for MS analysis. Gram-negative E. coli and Gram-
positive B. subtilis and S. aureus were chosen as model bacteria.
It should be noted that each test in this work was repeated
3–5 times to guarantee reproducibility and one mass spectrum
was chosen as a representative example and displayed. The
results showed that at least 103 cells of E. coli or B. subtilis or
S. aureus per sample spot were required to generate detectable
MS signals (Fig. S1, ESI†). In this test, the average diameter of
a sample spot on the target plate was 3 mm, while the size of
a bacterial cell is typically 0.5 to 10 mm and the diameter of the
laser beam used in the MALDI-TOF MS instrument is about
100 mm. As a result, analysis of a low number of bacteria cells
was accomplished using many “blind” laser shots, leading to
noise accumulation and limited detection sensitivity.This journal is © The Royal Society of Chemistry 2016
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View Article OnlineIn order to improve the sensitivity, it is necessary to decrease
the diameter of the sample spots, thereby increasing the sample
surface density and the chance of “eﬃcient” laser shots.
Recently, high-density micro-arrays for ultrasensitive MALDI-
TOF MS for the realization of single cell analysis were devel-
oped, where each sample spot was only 100 mm in diameter.20 In
the present work, the sample spots were conned within
800 mm. The sample spot size was optimized with the consid-
eration of MB utilization in later experiments. The presence of
MBs reduces MALDI eﬃciency when their surface density is too
high. The conned sample spot size was easily achievable in two
ways. The rst consisted of depositing samples onto the target
plate using a droplet-by-droplet protocol, and the second was
based on the utilization of a Bruker MTP AnchorChip target
plate (see Experimental section).
Taking advantage of the small sample spots, the sensitivity
of MALDI-TOF MS was signicantly enhanced. The MS nger-
print of E. coli was successfully obtained from as few as 10 to 102
cells (Fig. 1A). In the case of 10 cells, the cell number was
conrmed by counting under a microscope before matrix
deposition. Although the peak number decreased with the
decrease in E. coli cell number, peaks at 4136, 4313, 4547, 4830,
5392, 8227, 8615, and 9755 m/z (mass-to-charge ratio) appeared
reproducibly. Results for B. subtilis and S. aureus were similar
(Fig. 1B and C), with characteristic peaks at 4017, 4300, 4817,
4940, 6049, 6503, 6928, 8203, 8589, 9870, and 10 854 m/z
appearing reproducibly for B. subtilis, and peaks at 3445, 4110,
4308, 4817, 5035, 5445, 5528, 6891, and 8215 m/z appearingFig. 1 Direct MALDI-TOF MS ﬁngerprinting of intact (A) E. coli, (B) B. su
numbers: 105 cells (108 cells per mL 1 mL), 104 cells (107 cells per mL 1
and 10 cells (104 cells per mL  1 mL).
This journal is © The Royal Society of Chemistry 2016reproducibly for S. aureus. These peaks corresponded to
diﬀerent intracellular proteins (mainly ribosomal proteins),
which could serve as biomarkers to characterize the bacterial
species.24,25
Thus, a library of bacteria reference mass spectra was built
with the current data: 3 species (E. coli, B. subtilis, S. aureus) at
5 diﬀerent cells numbers (10, 102, 103, 104, 105) with 3–5 repe-
titions in each case. Representative spectra are shown in Fig. 1.
It is worth noting that existing commercial databases for
bacteria identication are normally built by collecting reference
spectra from large cell numbers, which can provide fruitful peak
information for highly condent identication.11,26 However, in
such a case, samples with high bacterial abundance are needed
to provide spectra with good similarity to the reference for
successful identication. Therefore, a large sample volume or
long bacteria culture time is required. In this work, reference
spectra were collected from a small number of cells as well and
this was demonstrated to be suﬃcient for bacteria
identication.Identication of bacteria based on mass spectra pattern
matching
For pattern matching-based bacteria identication, the experi-
mental spectrum obtained from a blood sample was compared
with every library spectrum, and spectral similarity scores were
calculated. Bacteria were identied according to the highest
score. The similarity score between two mass spectra (i and j)btilis, and (C) S. aureus with reduced sample spot size at diﬀerent cell
mL), 103 cells (106 cells per mL 1 mL), 102 cells (105 cells per mL 1 mL),
Chem. Sci., 2016, 7, 2987–2995 | 2989
Scheme 1 Schematic representation of the immunoaﬃnity MALDI-
TOF MS procedure.
Chemical Science Edge Article
O
pe
n 
A
cc
es
s A
rti
cl
e.
 P
ub
lis
he
d 
on
 2
6 
Ja
nu
ar
y 
20
16
. D
ow
nl
oa
de
d 
on
 2
4/
06
/2
01
6 
07
:5
8:
54
. 
 
Th
is 
ar
tic
le
 is
 li
ce
ns
ed
 u
nd
er
 a
 C
re
at
iv
e 
Co
m
m
on
s A
ttr
ib
ut
io
n 
3.
0 
U
np
or
te
d 
Li
ce
nc
e.
View Article Onlinewas calculated by the oen-used cosine correlation method,21
dened as:
cos ¼ yi
!
$yj
!Yi! $Yj!  ¼
Xl
k¼1
yikyjkﬃﬃﬃﬃﬃﬃﬃﬃﬃﬃﬃﬃﬃﬃXni
t¼1
Y 2it
s
$
ﬃﬃﬃﬃﬃﬃﬃﬃﬃﬃﬃﬃﬃﬃXnj
t¼1
Y 2jt
s
where y is the normalized intensity of a peak appearing in both
spectrum i and spectrum j (an identical peak), l is the number of
identical peaks in the two spectra, Y is the normalized intensity of
a peak appearing in a spectrum and n the number of peaks in
a spectrum. Only peaks with S/N $ 3 were considered. Peaks
appearing in diﬀerent spectra with D(m/z)/(m/z)# 1000 ppm were
considered as identical peaks. A tolerance of 1000 ppmwas chosen
according to the low resolving power of linear mode TOF analysis.
The scoring method was rst adopted to calculate the simi-
larity between the reference mass spectra as illustrated in the
previous section (not only the spectra shown in Fig. 1, but also
their repetitions). The similarity scores were calculated for three
groups: (i) the reference spectra obtained from the diﬀerent
bacteria (867 scores obtained); (ii) the reference spectra ob-
tained from the same bacteria, but at diﬀerent cell numbers
(342 scores obtained); and (iii) the reference spectra obtained
from diﬀerent repetitions of the same bacteria at the same cell
number (66 scores obtained). The frequency distribution of the
similarity scores in each group is shown in Fig. S2, ESI.† The
reference spectra of each bacteria were quite diﬀerent, with all
similarity scores # 0.1 (Fig. S2-A†). When considering the same
bacteria at diﬀerent cell numbers, the similarity scores range
from 0 to 1 (Fig. S2-B†). Meanwhile, the reference spectra ob-
tained from diﬀerent repetitions of the same bacteria at the
same cell number were quite similar, with almost all similarity
scores $ 0.8 (Fig. S2-C†).
Therefore, when the similarity score between a sample
spectrum and a reference spectrum is$0.8, we can assume that
the similarity is very high, as high as the similarity from diﬀerent
duplicated standard samples, and thereby the bacteria in the
sample can be identied as the reference one. A score of $ 0.8
was considered as the threshold for a successful identication.Immunoaﬃnity MALDI-TOF MS for bacteria identication
from spiked human blood serum and whole blood
When bacteria are present in a complex medium, i.e. blood
serum or whole blood, it is hard to eﬃciently perform direct
MALDI-TOF MS identication due to interference from that
medium. Thereby, a separation or extraction process is needed
before MS detection in order to purify and concentrate the
target bacteria. Due to the high specicity of immunoassays and
the convenience of magnetic separation, MBs modied with
anti-bacterial Abs were chosen for the enrichment and extrac-
tion of the target bacteria. This immunoaﬃnity MALDI-TOF MS
approach is shown in Scheme 1.
First, protein A/G-coated MBs were mixed with excess anti-
bacterial Abs to form Abs-MBs conjugates and avoid an aﬃnity
interaction between MBs and the components of the blood2990 | Chem. Sci., 2016, 7, 2987–2995serum or whole blood. The recombinant protein A/G on the
surface of MBs contains 6 binding domains (4 from protein A, 2
from protein G) to the Fc regions of the IgG isotype Abs.27 A
blocking buﬀer (PBST + 1% BSA) was used to further minimize
non-specic adsorption. Prior to the addition of Abs-MBs for
bacteria extraction, sample pre-treatment was conducted: blood
serum samples were diluted 10 times with PBST buﬀer to reduce
potential interference from serum proteins; whole blood
samples were treated with a stepwise centrifugation protocol to
purify the bacterial cells (see further details in the Experimental
section).28Neither the protein A/G-MBs nor the Abs generate any
signal in the mass range (2000–20 000 m/z) for bacteria identi-
cation (Fig. S3, ESI†). Therefore, all of the obtained magnetic
mixture, including the MBs, Abs and bacterial cells, was trans-
ferred onto a target plate via the droplet-by-droplet deposition
protocol for MALDI-TOF MS detection, followed by identica-
tion based on spectra pattern matching.
To maximize the eﬃciency of bacteria enrichment, experi-
mental conditions were optimized by comparing the quality of
the mass spectra obtained with various amounts of Abs-MBs
(Fig. S4, ESI†). An E. coli-spiked (104 cells per mL) aqueous
sample was chosen as the test sample. When amount of Abs-
MBs was too low, a small amount of bacteria was captured and
the obtained spectrum was of poor quality. In contrast, when
the amount of Abs-MBs too high, this reduced MALDI eﬃ-
ciency. Finally, 50 mg of Abs-MBs was chosen as the optimal
condition.
Before analysis of the bacteria-spiked samples, pure blood
serum and whole blood without any bacteria were analysed as
negative controls using the immunoaﬃnity MALDI-TOF MS
method. No peaks were observed in the mass range of 2000–
20 000 m/z (Fig. S5, ESI†), demonstrating the good specicity of
the immunoaﬃnity extraction. The blood serum and whole
blood spiked with a high concentration (108 cells per mL) of
E. coli, B. subtilis or S. aureus were then analysed. By pattern
matching, it was found that the resulting mass spectra showed
the highest similarity to the reference spectra of the corre-
sponding bacterial species at 105 cells. The similarity scores for
the blood serum and whole blood samples were 0.953  0.025
and 0.966 0.020 for E. coli, 0.976 0.009 and 0.959 0.020 for
B. subtilis and 0.993  0.005 and 0.986  0.006 for S. aureus, as
listed in Table S3, no. 1–18, ESI.† A representative spectrumThis journal is © The Royal Society of Chemistry 2016
Edge Article Chemical Science
O
pe
n 
A
cc
es
s A
rti
cl
e.
 P
ub
lis
he
d 
on
 2
6 
Ja
nu
ar
y 
20
16
. D
ow
nl
oa
de
d 
on
 2
4/
06
/2
01
6 
07
:5
8:
54
. 
 
Th
is 
ar
tic
le
 is
 li
ce
ns
ed
 u
nd
er
 a
 C
re
at
iv
e 
Co
m
m
on
s A
ttr
ib
ut
io
n 
3.
0 
U
np
or
te
d 
Li
ce
nc
e.
View Article Onlineobtained from each sample and a comparison with the corre-
sponding reference spectrum are shown in Fig. S6, ESI.†
When the bacterial concentration was gradually decreased, it
was found that bacteria with an abundance as low as 500 cells
per mL in blood serum (concentration before dilution) and 8000
cells per mL in whole blood could still be identied. The
resulting mass spectra displayed the highest similarity to the
reference spectra of the corresponding bacterial species at 10
cells, with all similarity scores > 0.9 (Table S3, no. 19–36, ESI†).
Representative sample spectra and comparison with the corre-
sponding reference are shown in Fig. 2 (see Table S1, ESI† for
a detailed peaks list). For blood serum samples with 500
bacterial cells per mL, the concentration was only 50 cells per
mL aer dilution. Considering that only 1 mL of sample was
used, it is reasonable that the obtained sample spectra should
match well with the reference spectra for 10 cells. The LODs for
the whole blood samples were not as good as those for the blood
serum samples. The main reason for this is the loss of bacterial
cells during the sample pre-treatment process.
The accuracy of the immunoaﬃnity MALDI-TOF MS method
was then evaluated. 20 whole blood samples spiked with
random concentrations of S. aureus (>8000 cells per mL) were
analysed using anti-S. aureus Abs-MBs. S. aureus was success-
fully identied from 19 samples, as the resulting spectra dis-
played the highest similarity (score > 0.8) to the reference
spectra of S. aureus (Table S3, no. 37–56, ESI†). For the
remaining sample, the resulting spectrum also best matched
with the reference spectrum of S. aureus, but the similarity score
was only 0.714. Another 20 whole blood samples spiked with
random concentrations (>8000 cells per mL) of E. coli or
B. subtilis were analysed as negative controls, also using anti-Fig. 2 Immunoaﬃnity MALDI-TOF mass spectra (in blue) for a low conc
(500 cells per mL) or whole blood (8000 cells per mL), and comparisons
10 cells with similarity scores calculated using the cosine correlation me
This journal is © The Royal Society of Chemistry 2016S. aureus Abs-MBs. No peaks were observed in the resulting
spectra. Therefore, the present method enables accurate iden-
tication of bacteria from blood samples.
In many cases, patients are infected with polymicrobial BSI
(i.e. BSI caused by more than one pathogen).29 Normal MALDI-
TOF MS is not eﬃcient for samples containing several bacterial
species. Proteins or membrane lipids from diﬀerent species can
make the resulting mass spectra too complicated to be ana-
lysed. A subculture, taking hours to days, is oen conducted to
provide pure bacterial cultures for identication. The immu-
noaﬃnity MALDI-TOF MS method is based on a highly specic
interaction between the bacteria and anti-bacterial Abs. There-
fore, it would be possible to identify target bacteria from multi-
species infected samples without a subculture. To prove this
concept, three groups of whole blood samples spiked simulta-
neously with S. aureus, E. coli, and B. subtilis were analysed with
anti-S. aureus Abs-MBs. The compositions of the samples were:
(A) 105 cells per mL S. aureus, 104 cells per mL E. coli, 104 cells
per mL B. subtilis; (B) 105 cells per mL S. aureus, 105 cells per mL
E. coli, 105 cells per mL B. subtilis; and (C) 105 cells per mL
S. aureus, 107 cells per mL E. coli, 107 cells per mL B. subtilis. As
shown in Table 1 (and Table S3, no. 57–65, ESI†), S. aureus was
correctly identied from all samples. When the concentrations
of both E. coli and B. subtilis were more than 500 times the
S. aureus concentration, S. aureus could no longer be identied
(data not shown). The extra high concentrations of E. coli and
B. subtilis decreased the chance of S. aureus binding with MBs.
Overall, the immunoaﬃnity MALDI-TOF MS method allows
bacteria identication from multi-species infected blood
samples when the relative concentrations of interferenceentration of (A) E. coli, (B) B. subtilis, and (C) S. aureus in blood serum
with the reference spectra (in green) of the corresponding species at
thod (r.int: relative intensity).
Chem. Sci., 2016, 7, 2987–2995 | 2991
Table 1 A list of spectra pattern matching results for three groups of
multi-species spiked whole blood samplesa
Sample Reference spectra
Similarity
score
A-1 10 S. aureus cells 0.990
A-2 102 S. aureus cells 0.993
A-3 102 S. aureus cells 0.991
B-1 10 S. aureus cells 0.991
B-2 10 S. aureus cells 0.985
B-3 10 S. aureus cells 0.992
C-1 102 S. aureus cells 0.969
C-2 10 S. aureus cells 0.982
C-3 10 S. aureus cells 0.970
a 1–3: three independent repetitions.
Chemical Science Edge Article
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View Article Onlinebacteria are not too high. This method shows potential for
polymicrobial BSI diagnosis.
To sum up, a sensitive method has been demonstrated for
the accurate and specic identication of bacteria from spiked
blood samples by combining a highly eﬃcient immunoaﬃnity
enrichment/separation and optimized MALDI-TOF MS detec-
tion. The method requires only 1 mL of sample. The LOD for
whole blood (8000 cells per mL) is still higher than the bacterial
concentration found in adult BSI patients and direct bacteria
identication from patient blood remains diﬃcult. However,
the much shorter BC period can be expected to magnify the
bacterial concentration to a detectable level. Moreover, this
method is particularly suitable for clinical diagnosis in child
patients, as BSI in child patients normally has a much higher
microorganism concentration (oen >100 CFU mL1).3,17Fig. 3 Immunoaﬃnity MALDI-TOF mass spectra (in blue) obtained
from four positive BC bottles and comparison with the reference
spectra (in green) with similarity scores calculated using the cosine
correlation method.Bacteria identication from BCs
In standard clinical diagnosis, blood samples collected from
patients are cultured in BC bottles to investigate the presence or
absence of bacteria. If bacteria are present, they can proliferate
in the bottles during the culture process. When the abundance
of bacteria is high enough, the bottles turn positive automati-
cally. For example, positive BacT/Alert® bottles indicate a high
bacterial abundance by a means of a colour change on the
bottom. Before the nal denitive identication step (e.g.
biochemical phenotyping), isolates from the positive bottles
undergo gram staining, plating, and subculture to further
magnify bacterial concentrations or to separate diﬀerent
bacteria.3
The developed immunoaﬃnity MALDI-TOF MS method was
used for bacteria identication directly from four clinical
positive BC bottles. Two of the bottles (bottle 1 and 2) were
E. coli positive. Another two (bottle 3 and 4) were S. aureus
positive. 1 mL of positive culture liquid was taken from each
bottle and analyzed with anti-E. coli or anti-S. aureus Abs-MBs.
Consequently, E. coli was correctly identied from bottle 1 and
2, as the resulting mass spectra displayed the highest similarity
to the reference spectra of 105 E. coli cells, with similarity scores
of 0.835 and 0.888, respectively (Table S3, no. 66–67, ESI†).
S. aureus was successfully identied from bottle 3 and 4, scoring2992 | Chem. Sci., 2016, 7, 2987–29950.981 and 0.954, respectively (Table S3, no. 68–69, ESI†). The
resulting mass spectra and a comparison with the reference
spectra are shown in Fig. 3 (see Table S2, ESI† for a detailed
peaks list). These results indicate that the present method can
identify bacteria directly from positive BCs, without the need for
a subculture. Therefore, this method can shorten the time for
BSI diagnosis.
For all four positive BC bottles, the resulting mass spectra
were comparable to the reference spectra with large numbers of
E. coli or S. aureus cells (105 cells), as shown in Fig. 3. This
implies that the bacterial concentrations are relatively high
when the BC bottles turn positive. As the LOD of the present
method in whole blood samples is 8000 cells per mL, it should
allow bacteria identication before the bottles turn positive. In
such a case, the BC time required for diagnosis could be
reduced. To demonstrate this concept, a time-step test was
conducted to investigate the inuence of BC time on the iden-
tication result.
5 mL of whole blood collected from a healthy adult was
spiked with E. coli at an initial concentration of either 102 or 103
cells per mL and cultured in a BacT/Alert® FA Plus BC bottle.
The initial concentrations of 102 and 103 cells per mL were
chosen in accordance with the normal bacterial concentration
found in BSI patients. For each concentration, four BC bottles (I,
II, III, IV) were prepared in parallel. For two of these bottle (I, II),
1 mL of culture liquid was removed and analyzed using the
immunoaﬃnity MALDI-TOF MS method every 2 hours. The
remaining two bottles (III, IV) were le untouched in order to
observe when they would turn positive automatically (indicated
by a colour change on the bottom).
The mass spectra obtained from the two parallel bottles
loaded with whole blood containing 102 cells per mL E. coli are
shown in Fig. 4A (bottle I) and S7-A, ESI† (bottle II). The best
pattern matching results for these spectra are displayed in
Fig. S8 and Table S3, no. 70–75, ESI.† At the beginning (0 hour of
BC), no characteristic peaks were detected, as the E. coliThis journal is © The Royal Society of Chemistry 2016
Fig. 4 Immunoaﬃnity MALDI-TOF mass spectra obtained from BC
bottles with initial E. coli concentrations of (A) 102 cells per mL and (B)
103 cells per mL in 5 mL of blood after diﬀerent BC times: 0 h, 2 h, 4 h,
6 h, 8 h and 10 h.
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View Article Onlineconcentration was below the LOD. Aer 2 hours, one peak atm/z
8226 appeared for both bottles. Considering a tolerance of
1000 ppm, this should be identical to the peak ofm/z 8227 in the
reference spectrum for 10 E. coli cells (Fig. S8, A-I, A-II, ESI†).
Aer 4 hours, more peaks were detectable, with a similarities of
0.927 (bottle I) and 0.867 (bottle II) to the reference spectrum for
10 E. coli cells (Fig. S8, B-I, B-II, ESI†). Good quality mass spectra
were obtained aer 6 hours, showing similarities of 0.959 and
0.876 to the reference spectrum for 104 and 103 E. coli cells,
respectively (Fig. S8, C-I, C-II, ESI†). Aer 8 hours, the obtained
spectra were similar to the reference spectrum for 105 E. coli
cells, with similarities of 0.913 and 0.897 for bottle I and II,
respectively (Fig. S8, D-I, D-II, ESI†). The obtained spectra didn't
change much when increasing the BC time (e.g. 10 h). There-
fore, the bacterial abundance was high enough for identica-
tion using the developed method aer 4 hours of BC.
Meanwhile, it was observed that the two untouched bottles
turned positive aer 10.5–11 hours of BC.
Mass spectra obtained from the two parallel loaded bottles
with whole blood containing 103 E. coli cells per mL are shown
in Fig. 4B (bottle I) and S7-B, ESI† (bottle II). The best pattern
matching results for these bottles are shown in Fig. S9 and
Table S3, no. 76–81, ESI.† The results indicated that E. coli could
be successfully identied aer 2 hours of BC. In comparison,
the two untouched bottles turned positive aer 9–9.5 hours of
BC.This journal is © The Royal Society of Chemistry 2016These results demonstrate that the present method is able to
identify bacteria before the BC bottles turn positive. Consid-
ering the time required for immunoaﬃnity MALDI-TOF MS
analysis (<2 hours), the entire identication process, from blood
collection to identication reports, could be completed within 4
to 6 hours, demonstrating this method’s potential application
for fast BSI diagnosis.
Utilization of appropriate Abs-coated MBs is critical for the
success of the present method. In clinical practice, it is neces-
sary to store Abs against common BSI pathogens, such as
Staphylococcus aureus, Staphylococcus epidermidis, Staphylo-
coccus hominis, Escherichia coli, Enterococcus faecium, Strepto-
coccus pneumoniae, Klebsiella pneumoniae, Acinetobacter
baumannii, and Enterobacter cloacae.29 To guide the selection of
suitable Abs, the pathogen species can be empirically pre-
judged according to the infection symptoms of a patient, and
then tested using the immunoaﬃnity MALDI-MS method. In
extreme cases, identication could always be carried out by
scanning the sample with the Abs-MBs bank. To further
increase the eﬃciency, Abs against particular strains of the
same bacterial species could also be stored and adopted.
Moreover, a library of reference spectra of a greater number of
bacterial species, especially common BSI pathogens at diﬀerent
cell numbers, should be built, which could be a future contin-
uation of the current work.
In addition to BSI diagnosis, this method can also be used
for the quality control of blood products (whole blood, platelet
and erythrocyte concentrates if not pathogen reduced) during
storage. For instance, bacterial strains involved in adverse
transfusion reactions such as Staphylococcus epidermis, Serratia
marcescens or Serratia liquefaciens could be tested in non-path-
ogen reduced blood products.30,31
Conclusions
In this work, an immunoaﬃnity MALDI-TOF MS method has
been developed for the identication of bacteria in human
blood samples at the species level. By comparing the resulting
sample spectra with references in a self-built library, bacteria
can be correctly identied from whole blood samples with LOD
of 8000 cells per mL (1 mL). The method is able to identify
bacteria from polybacterial blood samples, showing potential in
polymicrobial BSI diagnosis. It has also been successful in
direct bacteria identication from clinical positive BC bottles. A
time-step test suggests that bacteria can actually be identied
from BC bottles even before they turn positive. The culture time
required for diagnosis is also signicantly reduced. With this
method, the entire BSI diagnosis can be nished within half
a day.
Experimental
Materials
Goat polyclonal IgG isotype Abs against E. coli, rabbit polyclonal
IgG isotype Abs against B. subtilis and rabbit polyclonal IgG
isotype Abs against S. aureus were purchased from Abcam plc
(Cambridge, UK). Pierce™ protein A/G-coated MBs wereChem. Sci., 2016, 7, 2987–2995 | 2993
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View Article Onlinepurchased from Thermo Fisher Scientic Inc. (Waltham,
Massachusetts, USA). Human blood serum was purchased from
Bioreclamation LLC (New York, USA). Human whole blood was
donated by a healthy female in her 20s and was collected by the
Transfusion Interre´gional CRS, Lausanne, Switzerland. Positive
BC bottles with clinical BSI patients' blood and un-used BacT/
Alert® FA Plus BC bottles were provided by Hoˆpital du Valais
(Sion, Switzerland). Acetonitrile (HPLC grade) was purchased
from Aventor Performance Materials (Center Valley, PA, USA).
Triuoroacetic acid (TFA) (99.0%) was obtained from Acros
Organics (New Jersey, USA). 2,5-Dihydroxycinnamic acid (DHB),
Tween-20, bovine serum albumin (BSA), disodium hydrogen
phosphate dodecahydrate ($99.0%), sodium phosphate
monobasic dihydrate ($99.0%), and sodium chloride (NaCl)
($99.5%) were all purchased from Sigma-Aldrich (St. Gallen,
Switzerland). Deionized (DI) water (18.2 MU cm) was puried by
an alpha Q Millipore system (Zug, Switzerland), and used in all
aqueous solutions.
Bacterial cell culture
E. coli strain DH5a (obtained from Life Technologies) was grown
as a pre-culture in 2 mL of Luria-Bertani (LB) medium (Sigma-
Aldrich) at 37 C for 6 h with continuous shaking at 250 rpm.
100 mL of the E. coli DH5a pre-culture was added into 3 mL LB
and incubated overnight at 37 C with continuous shaking.
B. subtilis strain ATCC6633 (obtained from the American
Type Culture Collection, Rockville, Md.) and S. aureus strain Col
(provided by Lausanne University) were grown in 20 mL of LB
medium in 100 mL Erlenmeyer asks. Incubation was carried
out at 37 C for 16 h with continuous shaking at 180 rpm.
The concentration of bacteria in the culture media was
determined by measuring the optical density at 600 nm by
UV-visible absorption spectroscopy.
Direct MALDI-TOF MS ngerprinting of intact bacteria
Bacterial cells were separated from the growing media by
centrifugation (13 000 rpm  3 min), and washed three times
with DI water. Finally, the resulting cellular pellet was resus-
pended in DI water at a concentration of 108 cells per mL.
Bacteria solutions with diﬀerent concentrations were obtained
by dilution with DI water. 1 mL of each solution was deposited
on a MALDI target plate, and dried at room temperature (RT).
For sample deposition, three diﬀerent protocols were conduct-
ed. In the rst (the routine procedure), the whole 1 mL of solu-
tion was deposited on a Bruker ground steel target plate, and
the dried sample spot size was about 3 mm in diameter. In the
second, 1 mL of solution was deposited on the target plate with
four repetitions (0.25 mL in each repetition), droplet-by-droplet,
in order to keep the sample spot as small as possible (<0.8 mm
in diameter). In the third, a Bruker MTP AnchorChip target
plate was employed, where the dried sample spot from 1 mL of
a bacteria solution could be conned within a well that was
0.8 mm in diameter. DHB matrix (1 mL, 10 mg mL1 in
Vacetonitrile/Vwater/VTFA 50/49.5/0.1) was added to cover the dried
sample spots with the corresponding protocol for MALDI-TOF
MS analysis. Each test was repeated 3–5 times. A library of2994 | Chem. Sci., 2016, 7, 2987–2995bacteria reference mass spectra was built from the spectra ob-
tained with the reduced sample spot size.
Bacteria identication from human blood samples
50 mg of protein A/G (50.5 kDa)-coated MBs (1 mm in diameter)
were washed twice with PBST buﬀer and dispersed in 50 mL of
PBST buﬀer. An excess of Abs (2 mL  2 mg mL1) was added to
bind with MBs. The mixture was incubated for 30 min at RT
with continuous shaking. The obtained Abs-MBs were collected
using a magnetic stand and blocked with PBST buﬀer con-
taining 1% BSA. BSA was used to minimize non-specic
adsorption during the following immunoassay.
Blood serum samples or whole blood samples spiked with
diﬀerent concentrations of bacteria were prepared. To reduce
interference from the blood serum or whole blood, sample pre-
treatment was conducted. For the spiked serum samples,
0.1 mL of each sample was diluted with PBST buﬀer to 1 mL
before the addition of Abs-MBs. For the spiked whole blood
samples, 1 mL of each sample was diluted 6 times with DI water
and then centrifuged at 140g for 10 min to sediment the blood
cells. The supernatant was recovered and mixed with 2 mL of DI
water to lyse any residual erythrocytes. Aer centrifugation at
2000g for 5 min, a bacteria pellet was obtained, which was
washed with 1 mL DI water and nally resuspended in 300 mL of
PBST buﬀer. For the tests using the clinical positive BC bottles,
1 mL of culture uid was taken from each bottle with the help of
a sterile syringe and the bacteria were puried using the same
stepwise centrifugation protocol presented above.
Aerwards, 50 mg of Abs-MBs were added to capture the
bacterial cells. Aer incubation at 37 C for 30 min with
continuous shaking, the MBs were collected and washed twice
with a PBST buﬀer containing 0.1% BSA (1 mL) and once with
DI water (1 mL). The samples were then completely deposited
onto a normal MALDI target plate via a droplet-by-droplet
protocol or deposited onto an AnchorChip target plate. Aer
drying at RT, the sample spot was overlaid with DHB matrix for
MALDI-TOF MS detection.
Time-step test during the BC process
5 mL of human whole blood was spiked with E. coli cells with an
initial concentration of either 102 or 103 cells per mL. The
spiked blood was injected into a BacT/Alert® FA Plus BC bottle
and cultured at 37 C with continuous shaking. For each
concentration, four BC bottles were prepared in parallel. For
two of these bottles, during the culture process, 1 mL of culture
liquid was removed and analyzed with the proposed immu-
noaﬃnity MALDI-TOF MS method. The test was conducted
every 2 hours (0 h, 2 h, 4 h, 6 h, 8 h and 10 h). The remaining two
bottles were le untouched and observed until they turned
positive (indicated by an automatic colour change on the
bottom of the bottle, from grey-green to bright yellow).
MS detection and data analysis
MALDI-TOF MS analysis was performed on a Bruker MicroFlex
LRF in linear positive mode. The instrumental parameters were:
65% laser intensity, accumulation from 500 laser shots, 10.3This journal is © The Royal Society of Chemistry 2016
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View Article Onlinedetector gain and 400 ns delayed extraction time. Mass spectra
peak picking was performed with the mMass Open Source Mass
Spectrometry Tool (http://www.mmass.org). The similarity
scores obtained during the pattern matching process were
calculated using the cosine correlation method. All of the
mathematical calculations were conducted with “R” from the R
Foundation for Statistical Computing (http://www.R-
project.org). Only peaks with S/N $ 3 were considered, with
a mass tolerance of 1000 ppm. The similarity scores of each
sample spectrum compared to each library spectrum were
calculated, and the identication results were determined by
the highest score. A score$ 0.8 was the threshold for successful
identication.
Safety consideration
All practical activities with pathogenic bacterial strains were
conducted in a biosafety level 2 (P2) laboratory. Laboratory coats
and gloves were worn during the entire activity process and they
were never worn outside the laboratory. All bacterial waste was
disposed properly according to the safety guidelines. When
activities were nished, instruments, facilities and benches
were wiped down with 70% ethanol. Hands were washed with
soap and water before leaving the laboratory.
Live subject statement
All of the blood samples were collected under signed consent of
the donors. No research on genetic material was carried out.
Therefore, these samples were in agreement with the “Loi
fe´de´rale relative a` la recherche sur l'eˆtre humain, LRH – RS
810.30” and the “Ordonnance relative a` la recherche sur l'eˆtre
humain, ORH – RS 810.301”.
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